Cargando…

Does Bypass of the Proximal Small Intestine Impact Food Intake, Preference, and Taste Function in Humans? An Experimental Medicine Study Using the Duodenal-Jejunal Bypass Liner

The duodenal-jejunal bypass liner (Endobarrier) is an endoscopic treatment for obesity and type 2 diabetes mellitus (T2DM). It creates exclusion of the proximal small intestine similar to that after Roux-en-Y Gastric Bypass (RYGB) surgery. The objective of this study was to employ a reductionist app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aldhwayan, Madhawi M., Al-Najim, Werd, Ruban, Aruchuna, Glaysher, Michael Alan, Johnson, Brett, Chhina, Navpreet, Dimitriadis, Georgios K., Prechtl, Christina Gabriele, Johnson, Nicholas A., Byrne, James Patrick, Goldstone, Anthony Peter, Teare, Julian P., Le Roux, Carel W., Miras, Alexander Dimitri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145649/ https://www.ncbi.nlm.nih.gov/pubmed/35631283 http://dx.doi.org/10.3390/nu14102141

Ejemplares similares

Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial
por: Ruban, Aruchuna, et al.
Publicado: (2022)

The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
por: Ruban, Aruchuna, et al.
Publicado: (2018)

A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
por: Glaysher, Michael Alan, et al.
Publicado: (2017)

Effectiveness of different recruitment strategies in an RCT of a surgical device: experience from the Endobarrier trial
por: Ruban, Aruchuna, et al.
Publicado: (2019)

Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus
por: Chen, Ji-Hua, et al.
Publicado: (2022)

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
por: Ryder, Robert E.J., et al.
Publicado: (2023)

A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease
por: Ghoz, Hassan, et al.
Publicado: (2020)

Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis
por: Karlas, Thomas, et al.
Publicado: (2022)

Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity
por: Goldstone, Anthony P., et al.
Publicado: (2016)

Is duodeno-jejunal bypass liner superior to pylorus preserving bariatric surgery in terms of complications and efficacy?
por: Balint, Istvan Bence, et al.
Publicado: (2021)

Concurrent Placements of a Duodenal-Jejunal Bypass Liner and an Intragastric Balloon Among Severely Obese Patients: A Case Series
por: Sartoretto, Adrian, et al.
Publicado: (2019)

Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation
por: Betzel, B., et al.
Publicado: (2019)

Duodenal-jejunal bypass liner implantation provokes rapid weight loss and improved glycemic control, accompanied by elevated fasting ghrelin levels
por: Koehestanie, Parweez, et al.
Publicado: (2014)

The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study
por: van Rijn, Selwyn, et al.
Publicado: (2017)

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding
por: Scholtz, Samantha, et al.
Publicado: (2014)

Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
por: Okikawa, Shohei, et al.
Publicado: (2023)

Duodenal‐jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3‐year outcomes in the First National Health Service (NHS) EndoBarrier Service
por: Ryder, Robert E. J., et al.
Publicado: (2022)

Effects of preoperative exposure to a high-fat versus a low-fat diet on ingestive behavior after gastric bypass surgery in rats
por: Seyfried, Florian, et al.
Publicado: (2013)

Effect of Obesity Surgery on Taste
por: Al-Alsheikh, Alhanouf S., et al.
Publicado: (2022)

Conversion of Roux-en-Y gastric bypass to single anastomosis duodenal ileal bypass with sleeve gastrectomy with gastrogastric jejunal bridge
por: Dib, Victor Ramos Mussa, et al.
Publicado: (2022)

Sustained weight loss after duodenal–jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m(2): A retrospective cohort study
por: Boonchaya‐anant, Patchaya, et al.
Publicado: (2022)

The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials
por: Aldawsari, Malikah, et al.
Publicado: (2023)

Absence of Role of Dietary Protein Sensing in the Metabolic Benefits of Duodenal-Jejunal Bypass in the Mouse
por: Barataud, Aude, et al.
Publicado: (2017)

Medical Devices in Obesity Treatment
por: Ruban, Aruchuna, et al.
Publicado: (2019)

FIXING JEJUNAL MANEUVER TO PREVENT PETERSEN HERNIA IN GASTRIC BYPASS
por: MURAD-JUNIOR, Abdon José, et al.
Publicado: (2015)

Duodenal-Jejunal Bypass Surgery Reverses Diabetic Phenotype and Reduces Obesity in db/db Mice
por: Liang, Yongjun, et al.
Publicado: (2017)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
por: Yu, Hsin-Hsien, et al.
Publicado: (2019)

DUODENAL-JEJUNAL BYPASS REDUCES LIPID ACCUMULATION IN THE BROWN ADIPOSE TISSUE OF HYPOTHALAMIC OBESE RATS
por: CEGLAREK, Vanessa Marieli, et al.
Publicado: (2020)

A Comparison of Total Food Intake at a Personalised Buffet in People with Obesity, before and 24 Months after Roux-en-Y-Gastric Bypass Surgery
por: Kapoor, Natasha, et al.
Publicado: (2021)

Jejunal-Ileal Bypass and its Complications: Case Report and Review of the Literature
por: Khan, Arsalan, et al.
Publicado: (2020)

Duodenal-Jejunal Bypass Surgery Stimulates the Expressions of Hepatic Sirtuin1 and 3 and Hypothalamic Sirtuin1
por: Ha, Eunyoung, et al.
Publicado: (2018)

Effects and mechanism of duodenal-jejunal bypass and sleeve gastrectomy on GLUT2 and glucokinase in diabetic Goto–Kakizaki rats
por: Donglei, Zhou, et al.
Publicado: (2012)

Effect of duodenal-jejunal bypass surgery on glycemic control in type 2 diabetes: a randomized controlled trial
por: Petry, Tarissa Z., et al.
Publicado: (2015)

miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal–jejunal bypass
por: Guo, W, et al.
Publicado: (2016)

Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats
por: Cantelli, K.R., et al.
Publicado: (2017)

The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats
por: Gao, Yi, et al.
Publicado: (2021)

Alteration of Ileal lncRNAs After Duodenal–Jejunal Bypass Is Associated With Regulation of Lipid and Amino Acid Metabolism
por: Liang, Yongjun, et al.
Publicado: (2022)

Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure
por: Hollenbach, Marcus, et al.
Publicado: (2018)

Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial
por: Tripolt, Norbert Joachim, et al.
Publicado: (2018)

The Impact Once-Weekly Semaglutide 2.4 mg Will Have on Clinical Practice: A Focus on the STEP Trials
por: Alabduljabbar, Khaled, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_001hqus5kek6fbs5mejfio1mcg